More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

First Commerical Pancreas Treatment In Spain

Apr 12, 2022 at 11:39 PM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Apr 12, 2022 at 11:39 PM EDT

On 6ix: 6ix.com/news/first-commerical-pancreas-treatment-in-spain

Oncosil Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

  • Fully-Funded Trial Approved In GermanyMar 27, 2022
  • Half Yearly Report ResultsFeb 22, 2022
  • OncoSil approved for Innovation Funding (NUB) in GermanyFeb 2, 2022
  • PanCO Clinical Study on OncoSil Published in ESMO OpenDec 23, 2021
  • 2021 AGM CEO PresentationOct 18, 2021

Later from OncoSil Medical

  • OncoSil Signs Commercial Agreement With Hospital In SpainApr 28, 2022
  • OncoSil Launches $10m Capital RaisingApr 29, 2022
  • Clarification Of Non-Renouncable Entitlement Offer DetailsMay 1, 2022
  • OncoSil Entitlement Offer BookletMay 10, 2022
  • Entitlement Offer Results and Shortfall NotificationJun 9, 2022
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer